in a temperature-controlled environment. In this format, multiple replicate measurements can be made, increasing the precision of the assay and allowing the use of qualitycontrol materials in each assay. Although the CD assay may never become a routine clinical assay for the assessment of the oxidizability of LDL, it is useful for research and can now be applied to specimens from large clinical trials and epidemiologic surveys. 
Evaluation of the Measurement of Lysate Homocysteine in Patients with
Because of the increasing interest in routine clinical measurement of plasma total homocyst(e)ine (tHcy), it is necessary to simplify the critical preanalytical phase, especially the centrifugation step required immediately after blood collection to separate homocysteine-producing and -releasing blood cells from plasma (1) (2) (3) (4) . To overcome this procedural problem, which leads to falsely increased tHcy results when sample transport is prolonged, we recently developed a blood collection system that stabilizes tHcy in lysed whole blood (lysHcy) for at least 2 days at room temperature without requiring a centrifugation step (5 ) . Because of the dilution with Fig. 1 . Analysis of quality-control materials stored at Ϫ80°C.
Two quality-control materials were prepared, and aliquots were frozen at Ϫ80°C. For each assay, a vial of each material was thawed, the LDL was prepared, and the oxidation assay was performed in duplicate. The horizontal lines in each panel indicate the mean value of all assays over 37 weeks. No consistent trend was obvious for any of the oxidation parameters, which would indicate degradation of the quality-control materials. F, QC1; ---, mean of 20 assays; E, QC2; ----, mean of 18 assays. plasma with intracellular liquid, the lysHcy concentrations measured in the lysate system are lower than the homocysteine concentrations measured in the tHcy system; therefore, the aim of the present study was to evaluate the measurement of lysHcy in patients with symptomatic arterial disease and healthy volunteers, using the determination of tHcy as a reference method. tHcy and lysHcy determinations were compared with multiple linear regression analysis, taking into account age, and the concentrations of creatinine, folate, and vitamin B 12 .
We studied 224 consecutive patients (139 men and 85 women; ages 35-93 years) admitted for surgical repair of arterial disease, including 73 patients with high-grade carotid stenosis as classified by ultrasound and angiography according to the criteria of the European Carotid Surgery Trialists' study group (6 ) and 27 male patients presented with abdominal aortic aneurysm with a maximum diameter exceeding 5 cm. Peripheral arterial occlusive disease (PAOD) was present in 124 patients, 59 of whom suffered from rest pain or gangrene. Healthy volunteers (33 males and 58 females; ages 8 -82 years) were recruited mainly from employees of our hospital and reported no history of PAOD, heart disease, diabetes, thrombosis, cerebrovascular disease, or renal impairment. Their routine blood analyses, including hematological investigations, were within the appropriate health-related reference intervals. Of this group, 15% took occasional multivitamin supplements, and their nutritional histories were unremarkable. Informed consent was given by all individuals, and the study was approved by the ethics committee for our institution.
Venous blood for Hcy measurement was collected in tubes containing EDTA or in a specially prepared monovette containing a mixture of a lysing agent, EDTA, and citric acid (5 ). Serum was collected for measurement of vitamins and creatinine. All samples were taken in the morning, collected on ice, and transported to the laboratory within 60 min. After centrifugation of the EDTA blood, plasma was separated from blood cells and frozen at Ϫ30°C. Lysed whole blood was frozen at Ϫ30°C without any prior treatment.
The HPLC procedures for tHcy and lysHcy were similar (5 ) and based on the method of Vester and Rasmussen (7 ) . After a reduction step with phosphine and subsequent protein precipitation, the sulfhydryl compounds were derivatized, separated on a RP-18 column (LiChrosphere 100, 5 m particle size; Merck) and quantified by fluorescence detection (F1080; Merck). Serum creatinine was measured with the phenol-aminophenazone method (Hitachi 747; Boehringer Mannheim), and folate and vitamin B 12 were measured with an immunoassay analyzer (Access; Beckman Coulter). The reference intervals were as follows: folate, 6.8 -38.6 nmol/L; vitamin B 12 , 148 -703 pmol/L; creatinine, 62-115 mol/L for males and 44 -97 mol/L for females.
Results were expressed as means Ϯ SD. Differences between groups were tested with the Wilcoxon-MannWhitney-U-test. Regression analyses were performed according to Passing and Bablok (8 ) . All statistical calculations were performed with MedCalc ® (MedCalc Software).
We found mean tHcy and lysHcy concentrations of 16.3 Ϯ 7.8 and 9.3 Ϯ 4.5 mol/L for the 224 patients and 11.1 Ϯ 3.5 and 6.5 Ϯ 2.9 mol/L for the 91 volunteers. As expected, the differences in tHcy and lysHcy between patients and volunteers were significant (P Ͻ0.005) in both systems (Fig. 1 ). There were no significant differences in tHcy or lysHcy concentrations between the patient subgroups (carotid stenosis, abdominal aortic aneurysm, or PAOD). Folate did not differ significantly (P ϭ Multiple linear regression analysis (Table 1) showed that both tHcy and lysHcy correlated positively with creatinine (P Յ0.005) and age (P Ͻ0.005) and correlated Differences between volunteers and patients were significant for lysHcy (P Ͻ0.005) and tHcy (P Ͻ0.005). The bottoms of the boxes represent the 25th, and the tops of the boxes represent the 75th percentile. The lines within the boxes represent the 50th percentile (median value).
negatively with folate (P Ͻ0.005). Differences in the regression coefficients for lysHcy and tHcy reflected the different concentration ranges of these systems. Neither lysHcy nor tHcy depended significantly on vitamin B 12 concentrations. Goodness of fit statistics for tHcy and lysHcy were 0.249 and 0.250 for r 2 . Several well-designed cross-sectional and case-control studies have clearly shown evidence that tHcy is a major independent risk factor for PAOD, cardiovascular morbidity, and death (10 -12 ) . The determination of tHcy has been shown to be sensitive to preanalytical handling (1) (2) (3) (4) , and in daily routine, the determination of tHcy commonly lacks standardized preanalytical processing conditions. An accurate determination of tHcy is desirable for several reasons. Several studies of carotid and coronary atherosclerosis, myocardial infarction, and venous thrombosis indicate that there is a linear relationship between tHcy concentrations and risk, rather than a threshold value, and that tHcy is pathologically active even at concentrations below the currently discussed cutoff of 15 mol/L (13, 14 ) . Verhoef et al. (15 ) and Nygard et al. (12 ) found that increases of tHcy concentrations of up to 3 or 5 mol/L produced odds ratios or mortality ratios between 1.35 and 1.9. The mean increase of tHcy in EDTA blood is approximately 10% per hour if blood cells are not separated after blood collection (7, 16 ) . This corresponds diagnostically to an estimated 1.3-fold increase in risk for a patient if blood is left standing for 3 h, given an initial tHcy concentration of 10 mol/L. To avoid this overestimation of risk, the aim of the present study was to establish the robust lysHcy method (5 ) for a safe and clinically reliable determination of tHcy for routine clinical use.
We did not use the ROC to derive a cutoff for two reasons: the sensitivity and specificity for both tHcy and lysHcy are quite low because of a significant overlap (Fig.  1) of the respective distributions, and the two groups are not comparable in age. The association of tHcy and creatinine, described in 1992 by Chauveau et al. (17 ) , could be confirmed for both tHcy and lysHcy determinations (Table 1 ). In 13.8% of patients, creatinine concentrations exceeded the respective cutoff concentrations for males and females and were accompanied by increased tHcy (20.3 Ϯ 7.8 mol/L) and lysHcy (11.7 Ϯ 4.4 mol/ L). Of this group, 74% had tHcy concentrations Ͼ15 mol/L and 70% had lysHcy concentrations Ͼ8.5 mol/L.
Creatinine concentrations were not increased in any of our volunteers. Although the folate concentrations were similar in the patients and volunteers, regression analysis showed that there was a close relationship between folate and tHcy or lysHcy ( Table 1 ). The current lack of commercialized blood collection systems for lysHcy determination will be overcome in the near future: Bio-Rad Germany currently is establishing a similar system that uses stabilized lysed capillary blood instead of lysed venous blood. In summary, our data show that the prevalence of increased lysHcy is increased in patients with systemic atherosclerosis. Because of the 2-day stability of lysHcy in our blood collection system and the good comparability of tHcy and lysHcy determinations, the latter is the more reliable indicator for atherosclerotic risk assessment in the clinical routine, especially if rapid sample transport from the patient to the laboratory is not guaranteed. This work was supported by a grant from the Kommission Klinische Forschungsprojekte der Technischen Universität Mü nchen. We thank B. Matthes and S. Kaspar for skillful technical assistance and the performance of measurements, M. Scholz for statistical advice, and P. Luppa and M. Page for valuable advice and critical review the manuscript. 
